- •Ovarian cancer in women with LS develops at an early age, with a wide age-range of onset and at an early stage.
- •These LS associated ovarian cancers most often has an endometrioid or serous type histology with a good overall survival.
- •The early stage of ovarian cancer, in women with LS, could not be attributed to annual gynecological surveillance.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.Am. J. Surg. Pathol. 2012; 36: 163-172
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.Proc. Natl. Acad. Sci. U. S. A. 2011; 108: 18032-18037
- BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.Am. J. Obstet. Gynecol. 1998; 178: 670-677
- BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.Cancer. 2005; 104: 2807-2816
- Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.Clin. Cancer Res. 2008; 14: 1692-1700
- Hereditary ovarian carcinoma: heterogenity, molecular genetics, pathology and management.Mol. Oncol. 2009; 3: 97-137
- Cancer risk in mutation carriers of DNA-mismatch-repair genes.Int. J. Cancer. 1999; 81: 214-218
- Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.Clin. Genet. 2009; 75: 141-149
- Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.Int. J. Cancer. 2006; 120: 821
- The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.Gastroenterology. 2008; 135: 419-428
- The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to lynch syndrome.Familial Cancer. 2015; 14: 51-60
- MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.J. Clin. Oncol. 2001; 19: 4074-4080
- The risk of extra-colonic, extra-endometrial cancer in the lynch syndrome.Int. J. Cancer. 2008; 123: 444-449
- Ovarian cancer in Lynch syndrome; a systematic review.Eur. J. Cancer. 2016; 55: 65-73
- Pathological features and clinical behaviour of lynch syndrome-associated ovarian cancer.Gynecol. Oncol. 2017; 144: 491-495
- Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.Familial Cancer. 2009; 8: 391-397
- The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome.Gynecol. Oncol. 2013; 131: 304-308
- Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.Clin. Genet. 2013; 83: 359-364
- Screening for ovarian cancer: a pilot randomised controlled trial.Lancet. 1999; 353: 1207-1210
- No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.Br. J. Cancer. 2007; 96: 1335-1342
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).Lancet Oncol. 2009; 10: 327-340
- Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?.Int. J. Cancer. 2009; 124: 919-923
- Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) Cancer screening randomized controlled trial.JAMA. 2011; 305: 2295-2303
- Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial.Lancet. 2016; 387: 945-956
- International collaborative group on HNPCC. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.Gynecol. Oncol. 2001; 82: 223-228
- Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.Gynecol. Oncol. 2011; 121: 462-465
- Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas.Int. J. Cancer. 2013; 133: 2596-2608
http://www.STOET.nl, accessed 10 April 2017.
http://www.oncoline.nl/erfelijke darmkanker, 2015.
- High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR mutation carriers.Familial Cancer. 2009; 8: 145-151
- Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA).Cancer Epidemiol. Biomark. Prev. 2012; 21: 134-147
- Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.J. Med. Genet. 2010; 47: 99-102
- Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.Am. J. Hum. Genet. 2001; 68: 700-710
- French cancer genetics network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.JAMA. 2011; 305: 2304-2310
- Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.Familial Cancer. 2013; 12: 719-740
- Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.J. Med. Genet. 2009; 46: 593-597
- Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.Cancer Genet. Cytogenet. 2004; 153: 108-114
- Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.J. Clin. Oncol. 2009; 27: 4793-4797
- The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.Gynecol. Oncol. 2014; 133: 526
- Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.N. Engl. J. Med. 2006; 354: 261-269